Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2009

Open Access 01-02-2009 | Research article

Heavy metal exposure reverses genetic resistance to Chlamydia-induced arthritis

Authors: Robert D Inman, Basil Chiu

Published in: Arthritis Research & Therapy | Issue 1/2009

Login to get access

Abstract

Introduction

We have previously observed that Brown Norway (BN) rats display a relative resistance to experimental Chlamydia-induced arthritis. In the present study, we examine an environmental toxin, mercuric chloride (HgCl2), as a modulator of this innate resistance to arthritis.

Methods

To assess the effect of the heavy metal exposure, one group of rats received two subcutaneous injections of HgCl2 (1 mg/kg) 48 hours apart. Seven days later, the animals received the intra-articular injection of synoviocyte-packaged Chlamydia.

Results

Histopathology revealed that BN rats receiving only Chlamydia had a minimal cellular infiltration in the joint, which was predominantly mononuclear in character. In contrast, mercury-exposed rats had a marked exacerbation of the histopathological severity of the arthritis, and the infiltration was predominantly neutrophilic. Mercury exposure was also associated with marked enhancement in IgE levels and an alteration in IgG2a/IgG1 ratio, reflecting a Th2 shift. The local cytokine profile in the joint was markedly altered after mercury exposure, with a suppression of tumour necrosis factor-alpha and interferon-gamma but an enhancement of vascular endothelial growth factor. This was associated with decreased host clearance capacity reflected in enhanced bacterial load in both the spleen and the joint and was accompanied by enhanced detection of microbial antigens in the synovial tissues by immunohistological staining.

Conclusions

Genetically defined cytokine production in the joint defines the severity of reactive arthritis by dictating the local clearance of the pathogen. This interplay can be altered dramatically by heavy metal exposure, which results in suppression of protective cytokines in the microenvironment of the joint.
Appendix
Available only for authorised users
Literature
1.
go back to reference Inman RD, Chiu B: Synoviocyte-packaged Chlamydia trachomatis induces a chronic aseptic arthritis. J Clin Invest. 1998, 102: 1776-1782. 10.1172/JCI2983.PubMedCentralCrossRefPubMed Inman RD, Chiu B: Synoviocyte-packaged Chlamydia trachomatis induces a chronic aseptic arthritis. J Clin Invest. 1998, 102: 1776-1782. 10.1172/JCI2983.PubMedCentralCrossRefPubMed
2.
go back to reference Inman RD, Chiu B: Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats. Arthritis Rheum. 2006, 54: 499-507. 10.1002/art.21643.CrossRefPubMed Inman RD, Chiu B: Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats. Arthritis Rheum. 2006, 54: 499-507. 10.1002/art.21643.CrossRefPubMed
3.
go back to reference Fournié GJ, Cautain B, Xystrakis E, Damoiseaux L, Mas M, Lagrange D, Bernard I, Subra JF, Pelletier L, Druet P, Saoudi A: Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol Rev. 2001, 184: 145-160. 10.1034/j.1600-065x.2001.1840114.x.CrossRefPubMed Fournié GJ, Cautain B, Xystrakis E, Damoiseaux L, Mas M, Lagrange D, Bernard I, Subra JF, Pelletier L, Druet P, Saoudi A: Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol Rev. 2001, 184: 145-160. 10.1034/j.1600-065x.2001.1840114.x.CrossRefPubMed
4.
go back to reference Fournie GJ, Saoudi A, Druet P, Pelletier L: Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control. Autoimmun Rev. 2002, 1: 205-212. 10.1016/S1568-9972(02)00052-6.CrossRefPubMed Fournie GJ, Saoudi A, Druet P, Pelletier L: Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control. Autoimmun Rev. 2002, 1: 205-212. 10.1016/S1568-9972(02)00052-6.CrossRefPubMed
5.
go back to reference Gorrie MJ, Qasim FJ, Whittle CJ, Gillespie KM, Szeto CC, Nicoletti F, Bolton EM, Bradley JA, Mathieson PW: Exogenous type-1 cytokine modulate mercury-induced hyper-IgE in the rat. Clin Exp Immunol. 2000, 121: 17-22. 10.1046/j.1365-2249.2000.01261.x.PubMedCentralCrossRefPubMed Gorrie MJ, Qasim FJ, Whittle CJ, Gillespie KM, Szeto CC, Nicoletti F, Bolton EM, Bradley JA, Mathieson PW: Exogenous type-1 cytokine modulate mercury-induced hyper-IgE in the rat. Clin Exp Immunol. 2000, 121: 17-22. 10.1046/j.1365-2249.2000.01261.x.PubMedCentralCrossRefPubMed
6.
go back to reference Kiely PDW, Thiru S, Oliveira DBG: Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest. 1995, 73: 284-293.PubMed Kiely PDW, Thiru S, Oliveira DBG: Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest. 1995, 73: 284-293.PubMed
7.
go back to reference Qasim FJ, Thiru S, Mathieson PW, Oliveira DB: The time course and characterization of mercuric chloride-induced immunopathology in the Brown Norway rat. J Autoimmun. 1995, 8: 193-208. 10.1006/jaut.1995.0015.CrossRefPubMed Qasim FJ, Thiru S, Mathieson PW, Oliveira DB: The time course and characterization of mercuric chloride-induced immunopathology in the Brown Norway rat. J Autoimmun. 1995, 8: 193-208. 10.1006/jaut.1995.0015.CrossRefPubMed
8.
go back to reference Kosuda LL, Greiner DL, Bigazzi PE: Mercury induced renal autoimmunity in BN to Lew.1N chimeric rats. Cell Immunol. 1994, 155: 77-94. 10.1006/cimm.1994.1103.CrossRefPubMed Kosuda LL, Greiner DL, Bigazzi PE: Mercury induced renal autoimmunity in BN to Lew.1N chimeric rats. Cell Immunol. 1994, 155: 77-94. 10.1006/cimm.1994.1103.CrossRefPubMed
9.
go back to reference White KL, David DW, Butterworth LF, Klykken PC: Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model. Toxicol Lett. 2000, 12–113: 443-451. 10.1016/S0378-4274(99)00225-8.CrossRef White KL, David DW, Butterworth LF, Klykken PC: Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model. Toxicol Lett. 2000, 12–113: 443-451. 10.1016/S0378-4274(99)00225-8.CrossRef
10.
go back to reference Prouvost-Danon A, Abadie A, Sapin C, Bazin H, Druet P: Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat. J Immunol. 1981, 126: 699-792.PubMed Prouvost-Danon A, Abadie A, Sapin C, Bazin H, Druet P: Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat. J Immunol. 1981, 126: 699-792.PubMed
11.
go back to reference Prigent P, Saoudi A, Pannetier C, Graber P, Bonnefoy JY, Druet P, Hirsch F: Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest. 1995, 96: 1484-1489. 10.1172/JCI118185.PubMedCentralCrossRefPubMed Prigent P, Saoudi A, Pannetier C, Graber P, Bonnefoy JY, Druet P, Hirsch F: Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest. 1995, 96: 1484-1489. 10.1172/JCI118185.PubMedCentralCrossRefPubMed
12.
go back to reference Gillespie KM, Saoudi A, Kuhn J, Whittle CJ, Druet P, Bellon B, Mathieson PW: Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol. 1996, 26: 2388-2392. 10.1002/eji.1830261018.CrossRefPubMed Gillespie KM, Saoudi A, Kuhn J, Whittle CJ, Druet P, Bellon B, Mathieson PW: Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol. 1996, 26: 2388-2392. 10.1002/eji.1830261018.CrossRefPubMed
13.
go back to reference Roos A, Claessen N, Weening JJ, Aten J: Enhanced T lymphocyte expression of LFA-1, ICAM-1, and the TNF receptor family member OX40 in HgCl2-induced systemic autoimmunity. Scand J Immunol. 1996, 43: 507-518. 10.1046/j.1365-3083.1996.d01-66.x.CrossRefPubMed Roos A, Claessen N, Weening JJ, Aten J: Enhanced T lymphocyte expression of LFA-1, ICAM-1, and the TNF receptor family member OX40 in HgCl2-induced systemic autoimmunity. Scand J Immunol. 1996, 43: 507-518. 10.1046/j.1365-3083.1996.d01-66.x.CrossRefPubMed
14.
go back to reference Roos A, Claessen N, Schilder-Tol EJ, Weening JJ, Aten J: Differential expression of T-cell adhesion molecules and LFA-1 dependent intercellular adhesion in the HgCl2-induced autoimmunity and immune suppression. Scand J Immunol. 1998, 48: 389-396. 10.1046/j.1365-3083.1998.00414.x.CrossRefPubMed Roos A, Claessen N, Schilder-Tol EJ, Weening JJ, Aten J: Differential expression of T-cell adhesion molecules and LFA-1 dependent intercellular adhesion in the HgCl2-induced autoimmunity and immune suppression. Scand J Immunol. 1998, 48: 389-396. 10.1046/j.1365-3083.1998.00414.x.CrossRefPubMed
15.
go back to reference Inman RD, Perl A: Infectious agents in chronic rheumatic diseases. Arthritis and Allied Conditions: A Textbook of Rheumatology. Edited by: Koopman WJ. 2005, Philadelphia: Lippincott Williams & Wilkins, 647-678. 15 Inman RD, Perl A: Infectious agents in chronic rheumatic diseases. Arthritis and Allied Conditions: A Textbook of Rheumatology. Edited by: Koopman WJ. 2005, Philadelphia: Lippincott Williams & Wilkins, 647-678. 15
16.
go back to reference Hannu H, Inman RD, Granfors K, Leirisalo-Repo M: Reactive arthritis or postinfectious arthritis. Best Pract Res Clin Rheum. 2006, 20: 419-433. 10.1016/j.berh.2006.02.003.CrossRef Hannu H, Inman RD, Granfors K, Leirisalo-Repo M: Reactive arthritis or postinfectious arthritis. Best Pract Res Clin Rheum. 2006, 20: 419-433. 10.1016/j.berh.2006.02.003.CrossRef
17.
go back to reference Kuipers JG, Jurgen-Saathoff B, Bialowons A, Wollenhaupt J, Kohler L, Zeidler H: Detection of Chlamydia trachomatis in peripheral blood lymphocytes of reactive arthritis patients by polymerase chain reaction. Arthritis Rheum. 1998, 41: 1894-1895. 10.1002/1529-0131(199810)41:10<1894::AID-ART24>3.0.CO;2-E.CrossRefPubMed Kuipers JG, Jurgen-Saathoff B, Bialowons A, Wollenhaupt J, Kohler L, Zeidler H: Detection of Chlamydia trachomatis in peripheral blood lymphocytes of reactive arthritis patients by polymerase chain reaction. Arthritis Rheum. 1998, 41: 1894-1895. 10.1002/1529-0131(199810)41:10<1894::AID-ART24>3.0.CO;2-E.CrossRefPubMed
18.
go back to reference Branigan PJ, Gerard HC, Hudson AP, Schumacher HR, Pando J: Comparison of synovial tissue and synovial fluid as the source of nucleic acids for the detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum. 1996, 39: 1740-1746. 10.1002/art.1780391018.CrossRefPubMed Branigan PJ, Gerard HC, Hudson AP, Schumacher HR, Pando J: Comparison of synovial tissue and synovial fluid as the source of nucleic acids for the detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum. 1996, 39: 1740-1746. 10.1002/art.1780391018.CrossRefPubMed
19.
go back to reference Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL: Amplification of plasmid and chromosome Chlamydia DNA in synovial fluids of patients with reactive arthritis an undifferentiated seronegative spondyloarthropathies. Arthritis Rheum. 1995, 38: 1005-1013. 10.1002/art.1780380718.CrossRefPubMed Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL: Amplification of plasmid and chromosome Chlamydia DNA in synovial fluids of patients with reactive arthritis an undifferentiated seronegative spondyloarthropathies. Arthritis Rheum. 1995, 38: 1005-1013. 10.1002/art.1780380718.CrossRefPubMed
20.
go back to reference Gerard HC, Branigan PJ, Schumacher HR, Hudson AP: Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 1998, 25: 734-742.PubMed Gerard HC, Branigan PJ, Schumacher HR, Hudson AP: Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 1998, 25: 734-742.PubMed
21.
go back to reference Nanagara R, Li F, Beutler AM, Hudson A, Schumacher HR: Alteration of Chlamydia trachomatis biological behavior in synovial membranes: suppression of surface antigen production in reactive arthritis. Arthritis Rheum. 1995, 38: 1410-1417. 10.1002/art.1780381008.CrossRefPubMed Nanagara R, Li F, Beutler AM, Hudson A, Schumacher HR: Alteration of Chlamydia trachomatis biological behavior in synovial membranes: suppression of surface antigen production in reactive arthritis. Arthritis Rheum. 1995, 38: 1410-1417. 10.1002/art.1780381008.CrossRefPubMed
22.
go back to reference Gerard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP: Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs persistent infections. Microb Pathog. 2004, 36: 35-39. 10.1016/j.micpath.2003.08.005.CrossRefPubMed Gerard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP: Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs persistent infections. Microb Pathog. 2004, 36: 35-39. 10.1016/j.micpath.2003.08.005.CrossRefPubMed
23.
go back to reference Hess S, Rheinheimer C, Tidow F, Bartling G, Kaps C, Lauber J, Buer J, Klos A: The reprogrammed host: Chlamydia trachomatis-induced upregulation of glycoprotein 130 cytokines, transcription factors and antiapoptotic genes. Arthritis Rheum. 2001, 44: 2392-2401. 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I.CrossRefPubMed Hess S, Rheinheimer C, Tidow F, Bartling G, Kaps C, Lauber J, Buer J, Klos A: The reprogrammed host: Chlamydia trachomatis-induced upregulation of glycoprotein 130 cytokines, transcription factors and antiapoptotic genes. Arthritis Rheum. 2001, 44: 2392-2401. 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I.CrossRefPubMed
24.
go back to reference Virok D, Loboda A, Kari L, Nebozhyn M, Chang C, Nichols C, Endresz V, Gonczol E, Berencsi K, Showe MK, Showe LC: Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis. 2003, 188: 1310-1321. 10.1086/379047.CrossRefPubMed Virok D, Loboda A, Kari L, Nebozhyn M, Chang C, Nichols C, Endresz V, Gonczol E, Berencsi K, Showe MK, Showe LC: Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis. 2003, 188: 1310-1321. 10.1086/379047.CrossRefPubMed
25.
go back to reference Yang J, Hooper WC, Phillips DJ, Tondella ML, Talkington DF: Induction of proinflammatory cytokines in human lung epithelial cells during Chalmydia pneumoniae infection. Infect Immun. 2003, 71: 614-620. 10.1128/IAI.71.2.614-620.2003.PubMedCentralCrossRefPubMed Yang J, Hooper WC, Phillips DJ, Tondella ML, Talkington DF: Induction of proinflammatory cytokines in human lung epithelial cells during Chalmydia pneumoniae infection. Infect Immun. 2003, 71: 614-620. 10.1128/IAI.71.2.614-620.2003.PubMedCentralCrossRefPubMed
26.
go back to reference Yin Z, Braun J, Neure L, Wu P, Liu L, Eggens U, Sieper J: Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 1997, 40: 1788-1797. 10.1002/art.1780401010.CrossRefPubMed Yin Z, Braun J, Neure L, Wu P, Liu L, Eggens U, Sieper J: Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 1997, 40: 1788-1797. 10.1002/art.1780401010.CrossRefPubMed
27.
go back to reference Steiner G, Studnicka-Benke A, Witzmann G, Hofler E, Smolen J: Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis, and osteoarthritis. J Rheumatol. 1995, 22: 406-412.PubMed Steiner G, Studnicka-Benke A, Witzmann G, Hofler E, Smolen J: Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis, and osteoarthritis. J Rheumatol. 1995, 22: 406-412.PubMed
28.
go back to reference Bas S, Kvien TK, Buchs N, Fulpius T, Gabay C: Lower level of synovial fluid IFN-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamdyia trachomatis reactive arthritis. Rheumatology (Oxford). 2003, 42: 461-467. 10.1093/rheumatology/keg163.CrossRef Bas S, Kvien TK, Buchs N, Fulpius T, Gabay C: Lower level of synovial fluid IFN-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamdyia trachomatis reactive arthritis. Rheumatology (Oxford). 2003, 42: 461-467. 10.1093/rheumatology/keg163.CrossRef
29.
go back to reference Hansson M, Djerbi M, Rabbani H, Mellstedt H, Gharibdoost F, Hassan M, Depierre JW, Abedi-Valugerdi M: Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice. Immunology. 2005, 114: 428-437. 10.1111/j.1365-2567.2005.02105.x.PubMedCentralCrossRefPubMed Hansson M, Djerbi M, Rabbani H, Mellstedt H, Gharibdoost F, Hassan M, Depierre JW, Abedi-Valugerdi M: Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice. Immunology. 2005, 114: 428-437. 10.1111/j.1365-2567.2005.02105.x.PubMedCentralCrossRefPubMed
30.
go back to reference Inman RD, Payne U: Determinants of synoviocyte clearance of arthritogenic bacteria. J Rheumatol. 2003, 30: 1291-1297.PubMed Inman RD, Payne U: Determinants of synoviocyte clearance of arthritogenic bacteria. J Rheumatol. 2003, 30: 1291-1297.PubMed
31.
go back to reference Carratelli CR, Rizzo A, Paolillo R, Catania MR, Catalanotti P, Rossano F: Effect of nitric oxide on the growth of Chlamydophila pneumoniae. Can J Microbiol. 2005, 51: 941-947. 10.1139/w05-080.CrossRefPubMed Carratelli CR, Rizzo A, Paolillo R, Catania MR, Catalanotti P, Rossano F: Effect of nitric oxide on the growth of Chlamydophila pneumoniae. Can J Microbiol. 2005, 51: 941-947. 10.1139/w05-080.CrossRefPubMed
32.
go back to reference Roshick C, Wood H, Caldwell HD, McClarty G: Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun. 2006, 74: 225-238. 10.1128/IAI.74.1.225-238.2006.PubMedCentralCrossRefPubMed Roshick C, Wood H, Caldwell HD, McClarty G: Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun. 2006, 74: 225-238. 10.1128/IAI.74.1.225-238.2006.PubMedCentralCrossRefPubMed
33.
go back to reference Kim SH, Johnson VJ, Sharma RP: Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression inmurine macrophage: differential modulation of NF-κB and p38 MAPK signaling pathways. Nitric Oxide. 2002, 7: 67-74. 10.1016/S1089-8603(02)00008-3.CrossRefPubMed Kim SH, Johnson VJ, Sharma RP: Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression inmurine macrophage: differential modulation of NF-κB and p38 MAPK signaling pathways. Nitric Oxide. 2002, 7: 67-74. 10.1016/S1089-8603(02)00008-3.CrossRefPubMed
34.
go back to reference Huang CF, Liu SH, Lin-Shiau SY: Neurotoxicological effects of cinnabar (HgS) in mice. Toxicol Appl Pharmacol. 2007, 224: 192-201. 10.1016/j.taap.2007.07.003.CrossRefPubMed Huang CF, Liu SH, Lin-Shiau SY: Neurotoxicological effects of cinnabar (HgS) in mice. Toxicol Appl Pharmacol. 2007, 224: 192-201. 10.1016/j.taap.2007.07.003.CrossRefPubMed
35.
go back to reference Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, Toussirot E: High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol. 2003, 132: 158-162. 10.1046/j.1365-2249.2003.02101.x.PubMedCentralCrossRefPubMed Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, Toussirot E: High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol. 2003, 132: 158-162. 10.1046/j.1365-2249.2003.02101.x.PubMedCentralCrossRefPubMed
36.
go back to reference Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J: Inflammatory biomarkers, disease activity, and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis. 2008, 65: 511-517. 10.1136/ard.2007.071605. Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J: Inflammatory biomarkers, disease activity, and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis. 2008, 65: 511-517. 10.1136/ard.2007.071605.
37.
go back to reference Carratelli CR, Paolillo R, Rizzo A: Chlamydia pneumoniae stimulates the proliferation of HUVEC through the induction of VEGF by THP-1. Int Immunopharmacol. 2006, 7: 287-294. 10.1016/j.intimp.2006.10.007.CrossRefPubMed Carratelli CR, Paolillo R, Rizzo A: Chlamydia pneumoniae stimulates the proliferation of HUVEC through the induction of VEGF by THP-1. Int Immunopharmacol. 2006, 7: 287-294. 10.1016/j.intimp.2006.10.007.CrossRefPubMed
40.
go back to reference Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006, 296: 1885-1899. 10.1001/jama.296.15.1885.CrossRefPubMed Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006, 296: 1885-1899. 10.1001/jama.296.15.1885.CrossRefPubMed
41.
go back to reference Hemdan NY, Lehmann I, Wichmann G, Lehmann J, Emmrich F, Sack U: Immunomodulation by mercuric chloride in vitro: application of different cell activation pathways. Clin Exp Immuno1. 2007, 148: 325-337. 10.1111/j.1365-2249.2007.03338.x.CrossRef Hemdan NY, Lehmann I, Wichmann G, Lehmann J, Emmrich F, Sack U: Immunomodulation by mercuric chloride in vitro: application of different cell activation pathways. Clin Exp Immuno1. 2007, 148: 325-337. 10.1111/j.1365-2249.2007.03338.x.CrossRef
42.
go back to reference Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA: Wegener's granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum. 2004, 51: 656-664. 10.1002/art.20534.CrossRefPubMed Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA: Wegener's granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum. 2004, 51: 656-664. 10.1002/art.20534.CrossRefPubMed
Metadata
Title
Heavy metal exposure reverses genetic resistance to Chlamydia-induced arthritis
Authors
Robert D Inman
Basil Chiu
Publication date
01-02-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2610

Other articles of this Issue 1/2009

Arthritis Research & Therapy 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.